-
201
A Case of Solitary Necrotic Nodule Treated with Laparoscopic Hepatectomy: Spontaneous Regression of Hepatocellular Carcinoma?
Published 2013-01-01“…We here describe a case of SNN, whose central reticulin fibers within the nodule suggest the origin as hepatocellular carcinoma or other hepatocyte-origin tumors, treated with laparoscopic anatomical segmentectomy of the liver. …”
Get full text
Article -
202
Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
Published 2012-01-01“…The aim of this paper was to evaluate host immunity in liver cirrhosis (LC) patients with advanced hepatocellular carcinoma (aHCC) receiving sorafenib therapy. …”
Get full text
Article -
203
DNA Damage Sensor γ-H2AX Is Increased in Preneoplastic Lesions of Hepatocellular Carcinoma
Published 2013-01-01“…To evaluate the clinical usefulness of γ-H2AX in hepatocellular carcinoma (HCC), we measured the level of γ-H2AX in HCC, dysplastic nodule, and nontumorous liver diseases. …”
Get full text
Article -
204
Mutual causal effects between immune cells and hepatocellular carcinoma: a Mendelian randomization study
Published 2025-01-01Subjects: Get full text
Article -
205
Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis
Published 2024-12-01Subjects: Get full text
Article -
206
Tuftelin 1 Facilitates Hepatocellular Carcinoma Progression through Regulation of Lipogenesis and Focal Adhesion Maturation
Published 2022-01-01“…Hepatocellular carcinoma (HCC) is the most common type of primary liver malignancy with poor prognosis worldwide. …”
Get full text
Article -
207
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Published 2025-02-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
208
Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Published 2017-01-01“…Transarterial chemoembolization (TACE) is a good choice for hepatocellular carcinoma (HCC) treatment when surgery and liver transplantation are not feasible. …”
Get full text
Article -
209
Survival after Locoregional Treatments for Hepatocellular Carcinoma: A Cohort Study in Real-World Patients
Published 2012-01-01“…Evidence of relative effectiveness of local treatments for hepatocellular carcinoma (HCC) is scanty. We investigated, in a retrospective cohort study, whether surgical resection, radiofrequency ablation (RFA), percutaneous ethanol injection (PEI), and transarterial embolization with (TACE) or without (TAE) chemotherapy resulted in different survival in clinical practice. …”
Get full text
Article -
210
Highly efficient polyethylene glycol‐functionalised gold nanorods for photothermal ablation of hepatocellular carcinoma cells
Published 2019-10-01Subjects: Get full text
Article -
211
The Long Noncoding RNA LOXL1-AS1 Promotes the Proliferation, Migration, and Invasion in Hepatocellular Carcinoma
Published 2020-01-01“…To investigate the expression of long noncoding RNA lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) in hepatocellular carcinoma tissues and its effect on cell proliferation, migration, and invasion. …”
Get full text
Article -
212
Glucosamine Inhibits the Proliferation of Hepatocellular Carcinoma Cells by Eliciting Apoptosis, Autophagy, and the Anti-Warburg Effect
Published 2025-01-01“…Additionally, its impact on hepatocellular carcinoma (HCC) is not well understood. This study aimed to investigate the antitumor effects of GlcN and its underlying mechanism in a mouse HCC cell line, Hepa1-6. …”
Get full text
Article -
213
Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma.
Published 2025-01-01“…Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer and the second leading cause of cancer-related mortality globally. …”
Get full text
Article -
214
Integrated Bioinformatic Analysis Identifies Networks and Promising Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma
Published 2020-01-01“…Chronic infection with hepatitis B virus (HBV) has long been recognized as a dominant hazard factor for hepatocellular carcinoma (HCC) and accounts for at least half of HCC instances globally. …”
Get full text
Article -
215
Salidroside enhances 5-fluorouracil sensitivity against hepatocellular carcinoma via YIPF5-induced mitophagy
Published 2025-01-01Subjects: Get full text
Article -
216
Interaction of STIL with FOXM1 regulates SF3A3 transcription in the hepatocellular carcinoma development
Published 2025-01-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
217
Magnetic resonance imaging radiomics based on artificial intelligence is helpful to evaluate the prognosis of single hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
218
CDC25B Is a Prognostic Biomarker Associated With Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma
Published 2024-01-01“…Studies have suggested its carcinogenic potential in various cancers, but the role of CDC25B in the development of hepatocellular carcinoma (HCC) remains poorly understood. The aim of this study was to clarify the role of CDC25B in HCC using bioinformatics and experiments. …”
Get full text
Article -
219
To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinoma
Published 2025-02-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
220
Exosomes derived from syncytia induced by SARS-2-S promote the proliferation and metastasis of hepatocellular carcinoma cells
Published 2025-01-01Subjects: Get full text
Article